• Profile

Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States

JAMA Oncology May 08, 2019

Sanford NN, et al. - In this cross-sectional study, researchers used data from a comprehensive nationwide survey to determine the use of complementary and alternative medicine (CAM), as well as the associated rates of nondisclosure among patients with cancer and cancer survivors in the United States. In all, worse survival was observed in a small subset of patients who reported CAM use (n=258; 0.01% of the study population) vs patients who did not use CAM, and refusal of conventional cancer therapy seemed to mediate this finding. Overall, the investigators concluded that there is a need for an accurate evaluation of the prevalence of CAM use because CAM use has potentially serious, adverse, and wide-reaching implications in patients with cancer.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen